From wheat fields to Washington: a decades-old fear about skies and 'sprays' rises again, colliding with science, social media, and the machinery of federal policymaking.
KFF Health News
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Concomitant and bismuth quadruple regimens cleared ~90% of patients and outperformed triple therapy; sequential achieved ~84%. Adherence remained ~97% despite higher but manageable side effects.